Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 6Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Neoplasm Metastasis 2Pathologic Complete Response 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neuroma, Acoustic 1Neurofibromatosis 2 1Neoplasms 1Meningioma 1Malignant Female Reproductive System Neoplasm 1Hemangiosarcoma 1HER2-positive Breast Cancer 1Glioblastoma 1Gastrointestinal Neoplasms 1Fallopian Tube Neoplasms 1Ependymoma 1Endometrial Neoplasms 1Disease Progression 1Colonic Neoplasms 1Carcinoma, Lobular 1Brain Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Radiosurgery 2neratinib 1lutetium Lu 177 dotatate 1capivasertib 1avasopasem manganese 1Valproic Acid 1Taxes 1Sevoflurane 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Radiotherapy 1Propofol 1Nivolumab 1Multiparametric Magnetic Resonance Imaging 1Gemcitabine 1Everolimus 1Etoposide 1Cystectomy 1Clinical Trials, Phase II as Topic 1Clinical Trials, Phase I as Topic 1Cisplatin 1Carboplatin 1Blood Specimen Collection 1Biopsy 1Anesthesia, Inhalation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Disease Progression × neratinib × Clear all
NCT03919292 2026-04-21

Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca

Virginia Commonwealth University

Phase 1/2 Recruiting
83 enrolled
Gastrointestinal

Colonic Neoplasms, Pancreatic Neoplasms, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡